|
| Exchange Disseminated Time | Jagsonpal Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on
January 25, 2016, inter alia, to Consider the following:
1. To authorize Managing Director and/or Company Secretary to sign, execute and file the new Listing Agreement, pursuant to the amendments, with NSE & BSE and to comply other provisions in relation to the applicable provisions of Companies Act, 2013 as amended upto date.
2. To explore opportunities, in connection with optimum utilization of Company's assets and analyze the cost comparison / utilization of funds by alternate means. |
|
|